Literature DB >> 2297076

Binding of the blood group-reactive lectins to human adult kidney specimens.

L Laitinen1, H Juusela, I Virtanen.   

Abstract

The binding of a panel of blood group-reactive lectins to frozen sections of human kidney was studied with a special emphasis on reactivity with endothelia and basement membranes. The blood group A-reactive lectins, all specific for alpha-D-N-acetylgalactosamine (GalNAc), Helix aspersa (HAA), Helix pomatia (HPA), and Griffonia simplicifolia I-A4 (GSA-I-A4) agglutinins bound to the endothelium in specimens with blood groups A and AB. In other samples, these lectins reacted predominantly with tubular basement membranes, as well as with certain tubules. Both Dolichos biflorus (DBA) and Vicia villosa agglutinins (VVA), reported to react with blood group A1 substance, failed to reveal endothelia in most specimens, but bound differently to tubules in all blood groups. The blood group B-reactive lectins, specific for alpha-D-galactose (alpha-Gal) or GalNAc, respectively, GSA-I-B4 and Sophora japonica agglutinin (SJA), bound to the endothelia in specimens from blood group B or AB and in other specimens bound only to certain tubules. Among the blood group O-reactive lectins, specific for alpha-L-fucose (Fuc), Ulex europaeus I agglutinin (UEA-I) conjugates, but not other lectins with a similar nominal specificity, bound strongly to endothelia in specimens with blood group O. The UEA-I conjugates bound distinctly more faintly to endothelia in specimens of other blood groups. The present results indicate that lectins, binding to defined blood group determinants, react with endothelia in specimens of the respective blood group status. Furthermore, they suggest that basement membranes and some tubules in the human kidney show a distinct heterogeneity in their expression of saccharide residues, related to their blood group status.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297076     DOI: 10.1002/ar.1092260103

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  8 in total

1.  Helix pomatia agglutinin binds specifically to the Golgi apparatus in cultured human fibroblasts and reveals two Golgi apparatus-specific glycoproteins.

Authors:  I Virtanen
Journal:  Histochemistry       Date:  1990

2.  Morphological and cytogenetic studies of angiosarcoma in Stewart-Treves syndrome.

Authors:  L G Kindblom; G Stenman; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Histochemistry with Helix pomatia agglutinin in human germ cell tumors: detection of nongerminomatous components and correlation between HPA reactivity and radiosensitivity in germinomas.

Authors:  S Niikawa; N Sakai; H Yamada; W Zhang; A Hara; K Shimokawa
Journal:  Childs Nerv Syst       Date:  1993-08       Impact factor: 1.475

4.  Heterogeneous histochemical reaction pattern of the lectin Bandeiraea (Griffonia) simplicifolia with blood vessels of human full-term placenta.

Authors:  I Lang; T Hahn; G Dohr; G Skofitsch; G Desoye
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

5.  Lectin-binding carbohydrates in sexual differentiation of rat male and female gonads.

Authors:  K Fröjdman; R Malmi; L J Pelliniemi
Journal:  Histochemistry       Date:  1992-07

6.  Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.

Authors:  Alison Venable; Maisam Mitalipova; Ian Lyons; Karen Jones; Soojung Shin; Michael Pierce; Steven Stice
Journal:  BMC Dev Biol       Date:  2005-07-21       Impact factor: 1.978

7.  GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane.

Authors:  S A Brooks; D M Hall; I Buley
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

8.  Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.

Authors:  Junichi Yasutake; Yusuke Suzuki; Hitoshi Suzuki; Naoko Hiura; Hiroyuki Yanagawa; Yuko Makita; Etsuji Kaneko; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2015-06-23       Impact factor: 5.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.